Page last updated: 2024-08-22

zalcitabine and Hepatitis B Virus Infection

zalcitabine has been researched along with Hepatitis B Virus Infection in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	18 (85.71)	18.2507
2000's	2 (9.52)	29.6817
2010's	1 (4.76)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allweiss, L; Bierwolf, J; Dandri, M; Lütgehetmann, M; Matthes, E; Petersen, J; Pollok, JM; Volz, T; Warlich, M	1
Mitra, AK; Patel, J	1
de Man, RA; Heijtink, RA; Honkoop, P; Schalm, SW	1
Bartholomew, M; Dienstag, JL; Perrillo, RP; Rubin, M; Schiff, ER; Vicary, C	1
Merigan, TC	1
Condreay, LD; Daluge, SM; Ellis, MN; Furman, PA; Jansen, RW; Johnson, LC; Paff, MT; Painter, GR; Powdrill, TF; Selleseth, DW	1
de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW	2
Benhamou, Y; Dohin, E; Gentilini, M; Huraux, JM; Katlama, C; Lunel-Fabiani, F; Opolon, P; Poynard, T	1
Gardner, MF; Hostetler, KY; Korba, BE; Sridhar, CN	1
Cheng, YC; Dutschman, GE; Lin, TS; Liu, MC; Luo, MZ; Pai, SB	1
Boehme, R; Bonhoeffer, S; Hill, AM; McDade, H; Nowak, MA; Thomas, HC	1
Grimm, I	1
Korba, BE	1
Bonino, F; d'Urso, N; Ponzetto, A; Zahm, FE	1
Biron, K; Botteron, C; Cecchi, A; Cullen, JM; Davis, MG; Dunn, SE; Frick, L; Goulding, A; Linsey, D; Linzey, D; Paff, MT; Smith, SL	1
Prescott, LM	1
Rubin, M	1
Chang, CN; Cheng, YC; Skalski, V; Zhou, JH	1
Gerber, MA; Lampertico, P; Malter, JS	1

Reviews

3 review(s) available for zalcitabine and Hepatitis B Virus Infection

Article	Year
ACH-126443 Achillion/Yale University. Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:11 Topics: Animals; Clinical Trials as Topic; Hepatitis B; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Technology, Pharmaceutical; Zalcitabine	2002
New nucleoside analogues for chronic hepatitis B. Journal of hepatology, 1995, Volume: 22, Issue:1 Suppl Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinical; Famciclovir; Hepatitis B; Humans; Lamivudine; Nucleosides; Zalcitabine	1995
New developments in antiviral therapy for chronic hepatitis B infection. Scandinavian journal of gastroenterology. Supplement, 1995, Volume: 212 Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Lamivudine; Treatment Outcome; Zalcitabine	1995

Trials

2 trial(s) available for zalcitabine and Hepatitis B Virus Infection

Article	Year
A preliminary trial of lamivudine for chronic hepatitis B infection. The New England journal of medicine, 1995, Dec-21, Volume: 333, Issue:25 Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; DNA, Viral; Double-Blind Method; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zalcitabine	1995
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet (London, England), 1995, Feb-11, Volume: 345, Issue:8946 Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Virus Replication; Zalcitabine	1995

Other Studies

16 other study(ies) available for zalcitabine and Hepatitis B Virus Infection

Article	Year
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice. Antiviral therapy, 2012, Volume: 17, Issue:4 Topics: Animals; Antiviral Agents; Chimera; Cytidine; DNA, Viral; Hepatitis B; Humans; Lamivudine; Mice; Mice, SCID; Molecular Structure; Urokinase-Type Plasminogen Activator; Viremia; Zalcitabine	2012
Hepatitis B reactivation after lamivudine. Lancet (London, England), 1995, Oct-28, Volume: 346, Issue:8983 Topics: Adult; Alanine Transaminase; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Prednisone; Recurrence; Virus Activation; Zalcitabine	1995
A quarter-century of antiviral therapy. The New England journal of medicine, 1995, Dec-21, Volume: 333, Issue:25 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Zalcitabine; Zidovudine	1995
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:3 Topics: alpha-Fetoproteins; Animals; Antiviral Agents; Biological Availability; Cell Line; DNA, Viral; Emtricitabine; Hepatitis B; Hepatitis B virus; Humans; Mice; Polymerase Chain Reaction; Virus Replication; Zalcitabine	1994
Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice. Antiviral research, 1994, Volume: 24, Issue:1 Topics: Animals; Antiviral Agents; Drug Carriers; Hepatitis B; Liposomes; Liver; Mice; Phosphatidylglycerols; Prodrugs; Tissue Distribution; Tritium; Zalcitabine	1994
Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro. Biochemical pharmacology, 1994, Jan-20, Volume: 47, Issue:2 Topics: Antiviral Agents; Cells, Cultured; DNA; Hepatitis B; Hepatitis B virus; HIV-1; Stereoisomerism; Virus Replication; Zalcitabine	1994
Viral dynamics in hepatitis B virus infection. Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-30, Volume: 93, Issue:9 Topics: Alanine Transaminase; Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Models, Biological; Regression Analysis; Reverse Transcriptase Inhibitors; Time Factors; Viremia; Virus Replication; Zalcitabine	1996
Lamivudine: a magic bullet for chronic hepatitis B? Gastroenterology, 1996, Volume: 111, Issue:1 Topics: Antiviral Agents; Chronic Disease; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Zalcitabine	1996
In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral research, 1996, Volume: 29, Issue:1 Topics: Acyclovir; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatoblastoma; Humans; Interferon-alpha; Lamivudine; Tumor Cells, Cultured; Virus Replication; Zalcitabine	1996
Treatment of woodchuck hepatitis virus infection in vivo with 2', -3'-dideoxycytidine (ddC) and 2',-3'-dideoxycytidine monophosphate coupled to lactosaminated human serum albumin (L-HSA ddCMP). Liver, 1996, Volume: 16, Issue:2 Topics: Animals; Deoxycytosine Nucleotides; Dideoxynucleotides; DNA, Viral; Drug Carriers; Female; Hepatitis B; Hepatitis B Virus, Woodchuck; Male; Marmota; Serum Albumin; Viremia; Virus Replication; Zalcitabine	1996
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:10 Topics: Animals; Antiviral Agents; DNA, Viral; Emtricitabine; Half-Life; Hepatitis B; Hepatitis B Virus, Woodchuck; Liver; Marmota; Stereoisomerism; Zalcitabine	1997
Lamivudine useful against hepatitis B-HIV co-infection. Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:5 Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Virus Replication; Zalcitabine; Zidovudine	1995
A closer look at 3TC. Interview by Mark Mascolini. Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:6 Topics: Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Zalcitabine; Zidovudine	1995
ViroLogic announces agreement with Achillion. Pharmacogenomics, 2002, Volume: 3, Issue:2 Topics: Clinical Trials, Phase II as Topic; Cooperative Behavior; Drug Industry; Drug Resistance, Viral; Female; Hepatitis B; HIV Infections; Humans; Zalcitabine	2002
Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents. The Journal of biological chemistry, 1992, Nov-05, Volume: 267, Issue:31 Topics: Antiviral Agents; Base Sequence; Biological Transport; Cells, Cultured; Deoxycytidine Kinase; Hepatitis B; Hepatitis B virus; Humans; In Vitro Techniques; Lamivudine; Mitochondria; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Oligodeoxyribonucleotides; Phosphorylation; Zalcitabine	1992
Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics. Hepatology (Baltimore, Md.), 1991, Volume: 13, Issue:3 Topics: Antiviral Agents; Dideoxynucleosides; DNA Replication; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; In Vitro Techniques; Interferon Type I; Stavudine; Vidarabine; Vidarabine Phosphate; Virus Replication; Zalcitabine; Zidovudine	1991